Endocrinology, Vol 124, 2995-3002, Copyright © 1989 by Endocrine Society

ARTICLES

Antagonism of contractants and relaxants at the level of intracellular calcium and phosphoinositide turnover in the rat uterus

K Anwer, JA Hovington and BM Sanborn
Department of Biochemistry and Molecular Biology, University of Texas Medical School, Houston 77030.

The effects of the uterine relaxants relaxin and isoproterenol on intracellular free calcium and inositol phosphate formation were investigated in rat myometrium. Preincubation of fura-2-loaded myometrial cell suspensions with relaxin and isoproterenol inhibited the oxytocin-induced stimulation of intracellular free calcium, with EC50 values of 0.02 and 1.0 microM, respectively. Pretreatment of cells with pertussis toxin or replacement of extracellular calcium with 2 mM EGTA inhibited the oxytocin-induced increase in intracellular calcium by 47% and 50%, respectively, but did not inhibit the action of relaxin. (Bu)2cAMP and forskolin also inhibited the effect of oxytocin on intracellular calcium. In uterine strips prelabeled with [3H]inositol, oxytocin stimulated a dose-dependent accumulation of inositol monophosphate, inositol bisphosphate, and inositol trisphosphate, with and EC50 of 0.38 microM, and pertussis toxin inhibited this effect. Relaxin, isoproterenol, chlorophenylthio-cAMP, and forskolin inhibited the oxytocin-stimulated formation of inositol monophosphate, inositol bisphosphate, and inositol trisphosphate. The effect of relaxin on inositol trisphosphate formation was dose dependent, with an EC50 of 0.1 microM. Relaxin and isoproterenol also inhibited inositol phosphate formation in myometrial cells. These data demonstrate the attenuation of contractant-induced elevation in myometrial intracellular calcium and phosphoinositide turnover by uterine relaxants and suggest that these actions may be related. In addition, they provide additional evidence that cAMP-mediated mechanisms may be involved in mediating uterine relaxation.

This article has been cited by other articles:

				B. T. Nguyen, L. Yang, B. M. Sanborn, and C. W. Dessauer Phosphoinositide 3-Kinase Activity Is Required for Biphasic Stimulation of Cyclic Adenosine 3',5'-Monophosphate by Relaxin Mol. Endocrinol., June 1, 2003; 17(6): 1075 - 1084. [Abstract] [Full Text] [PDF]

				Z. Ruttner, T. Ivanics, D. W. Slaaf, R. S. Reneman, A. Toth, and L. Ligeti In Vivo Monitoring of Intracellular Free Calcium Changes During Uterine Activation By Prostaglandin F2{alpha} and Oxytocin Reproductive Sciences, September 1, 2002; 9(5): 294 - 298. [Abstract] [PDF]

				M. Yang, W. Wang, M. Zhong, A. Philippi, O. Lichtarge, and B. M. Sanborn Lysine 270 in the Third Intracellular Domain of the Oxytocin Receptor is an Important Determinant for G{alpha}q Coupling Specificity Mol. Endocrinol., April 1, 2002; 16(4): 814 - 823. [Abstract] [Full Text] [PDF]

				B. M. Sanborn Relationship of Ion Channel Activity to Control of Myometrial Calcium Reproductive Sciences, January 1, 2000; 7(1): 4 - 11. [Abstract] [PDF]

				K. L. Dodge, D. W. Carr, C. Yue, and B. M. Sanborn A Role for AKAP (A Kinase Anchoring Protein) Scaffolding in the Loss of a Cyclic Adenosine 3',5'-Monophosphate Inhibitory Response in Late Pregnant Rat Myometrium Mol. Endocrinol., December 1, 1999; 13(12): 1977 - 1987. [Abstract] [Full Text]

				K. L. Dodge, D. W. Carr, and B. M. Sanborn Protein Kinase A Anchoring to the Myometrial Plasma Membrane Is Required for Cyclic Adenosine 3',5'-Monophosphate Regulation of Phosphatidylinositide Turnover Endocrinology, November 1, 1999; 140(11): 5165 - 5170. [Abstract] [Full Text]

				J. J. Evans Modulation of Gonadotropin Levels by Peptides Acting at the Anterior Pituitary Gland Endocr. Rev., February 1, 1999; 20(1): 46 - 67. [Abstract] [Full Text]

				M. I. Rudolph, C. Oviedo, E. Vega, L. Martínez, K. Reinicke, M. Villar, and L. Villán Oxytocin Inhibits the Uptake of Serotonin into Uterine Mast Cells J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 389 - 394. [Abstract] [Full Text]

				K. L. Dodge and B. M. Sanborn Evidence for Inhibition by Protein Kinase A of Receptor/G{alpha}q/Phospholipase C (PLC) Coupling by a Mechanism Not Involving PLC{beta}2 Endocrinology, May 1, 1998; 139(5): 2265 - 2271. [Abstract] [Full Text] [PDF]